SPDR S&P Pharmaceuticals ETF (XPH): Price and Financial Metrics ETF
XPH Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
Current price | $39.33 | 52-week high | $45.62 |
Prev. close | $39.09 | 52-week low | $34.67 |
Day low | $39.06 | Volume | 3,743 |
Day high | $39.33 | Avg. volume | 42,451 |
50-day MA | $42.41 | Dividend yield | 1.49% |
200-day MA | $41.03 |
XPH Stock Price Chart Interactive Chart >
SPDR S&P Pharmaceuticals ETF (XPH) ETF Bio
The investment objective of the SPDR S&P Pharmaceuticals ETF is to provide investment results that correspond generally to the total return performance of the S&P Pharmaceuticals Select Industry Index.
XPH ETF Info
Issuer | State Street Global Advisors |
Expense Ratio | 0.35% |
Underlying Index | S&P Pharmaceuticals Select Industry Index |
Asset Class | Equity |
Sector | Health & Biotech ETFs |
Assets Under Management (AUM) | 189.57M |
Net Asset Value (NAV) | $39.08 |
Options? | Yes |
Total Holdings | 44 |
XPH Top Holdings
Symbol | Company | % of Total |
ITCI | INTRA CELLULAR THERAPIES INC | 5.34% |
MRK | MERCK + CO. INC. | 5.07% |
PRGO | PERRIGO CO PLC | 5.01% |
OGN | ORGANON + CO | 5% |
CTLT | CATALENT INC | 4.88% |
PFE | PFIZER INC | 4.76% |
AXSM | AXSOME THERAPEUTICS INC | 4.75% |
LLY | ELI LILLY + CO | 4.74% |
VTRS | VIATRIS INC | 4.65% |
JNJ | JOHNSON + JOHNSON | 4.59% |
XPH Price Returns
1-mo | -8.49% |
3-mo | -6.64% |
6-mo | 12.11% |
1-year | -4.26% |
3-year | -17.92% |
5-year | 3.30% |
YTD | -5.12% |
2023 | 2.97% |
2022 | -9.83% |
2021 | -10.54% |
2020 | 14.68% |
2019 | 25.61% |
XPH Dividends
Ex-Dividend Date | Type | Payout Amount | Change | ||||||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |